Already beavering away at building a US commercial operation, MorphoSys {$MOR} is now bearing down on Novartis and Gilead with a potential CAR-T killer soon to be put into the hands of US regulators.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,